Martha Morrell - 30 Jan 2024 Form 4 Insider Report for NeuroPace Inc (NPCE)

Signature
/s/ Irina Ridley, Attorney-In-Fact
Issuer symbol
NPCE
Transactions as of
30 Jan 2024
Net transactions value
-$208,965
Form type
4
Filing time
01 Feb 2024, 21:47:32 UTC
Previous filing
26 Jan 2024
Next filing
06 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NPCE Common Stock Sale $170,004 -11,262 -10% $15.10 97,937 30 Jan 2024 Direct F1, F2
transaction NPCE Common Stock Sale $28,990 -1,923 -2% $15.08 96,014 31 Jan 2024 Direct F1, F3
transaction NPCE Common Stock Sale $9,971 -663 -0.69% $15.04 95,351 01 Feb 2024 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.165, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.125, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.08, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.